Zobrazeno 1 - 10
of 811
pro vyhledávání: ''
Autor:
Xiaohong Pan, Lei Pan, Minjie Mao, Xiao-bo Ji, Xiao-qing Huang, Caihong Wang, Junke Qiu, Yang Zhou, Jiekun Xu
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-8 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Disseminated nocardiosis is liable to be misdiagnosed owing to the non-specific clinical manifestations and laboratory/imaging findings. Metagenomic next-generation sequencing (mNGS) is a culture-independent and rapid method for direct ide
Autor:
Adwoa K. A. Afrane, Seth Agyeman, Yakubu Alhassan, Seth N. Owiafe, Kwamena W. Sagoe, Bamenla Q. Goka, Alfred Yawson, Lorna Renner, Awewura Kwara
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Children living with human immunodeficiency virus (HIV) infection require lifelong effective antiretroviral therapy (ART). The goal of ART in HIV-infected persons is sustained viral suppression. There is limited information on virological
Autor:
Eva Heinz, Janelisa Musaya, Patrick Noah, Nicholas A. Feasey, Vincent Samuel Phiri, Gabriel Kambale Bunduki
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-13 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Uropathogenic Escherichia coli (UPEC) are amongst the most frequent causes of urinary tract infections. We report a systematic review and meta-analysis of virulence factors and antimicrobial resistance of UPEC isolated from urinary tract i
Autor:
Haibo Ding, Lin Wang, Zhen Wang, Minghui An, Bin Zhao, Xiaoxu Han, Lu Wang, Xin Li, Wei Song, Xue Dong, Wen Tian
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-6 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background To assess transmitted drug resistance (TDR) to tenofovir (TDF)/emtricitabine (FTC), using as pre-exposure prophylaxis, among newly diagnosed human immunodeficiency virus-1 (HIV-1)-infected residents in Shenyang city, northeast China. Metho
Autor:
Fernando Achinelli, Gerardo Andino, Maria Bangher, Paola Itati Reynoso, Antonia Cristina Aquino, Jorge Ojeda, Silvana Dellamea, Victor Flores, María Gabriela Aguirre, Elba Meza, Carolina N. Martemucci, Pablo Kawerin, Fabian Plano, Mariana Elizabeth Robledo, Claudia Campias, Hector Andres Guglielmone, Noelia Carolina Sosa, Evangelina Chaparro Campias, Rodrigo Zoni, Maria Mercedes Vernengo, Silvina Maria Martinez, Joaquina Maria Guarrochena, Natalia E. Ruiz Diaz, Diego Farizano Salazar, Julio Vallejos, Maria Fernanda Medina, Angelina Bobadilla, Silvina Villamandos, Juan Emanuel Segovia
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. Objective
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-6 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Oral beta-lactam antimicrobials are not routinely tested against Streptococcus pneumoniae due to presumed susceptibility based upon penicillin minimum inhibitory concentration (MIC) testing. Currently, Clinical and Laboratory Standards Ins
Autor:
Grahame Mtui, Semvua B. Kilonzo, Paulina M. Manyiri, Daniel W. Gunda, Fredrick Kalokola, Elichilia R. Shao, Fatma A. Bakshi, Hyasinta Jaka, Alex Stephano, David C. Majinge
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Methadone therapy clinics have been recently introduced in Tanzania, aiming at reducing risk behaviors and infection rates of viral hepatitis and HIV among people who use drugs. The objective of this study was to estimate the prevalence, a
Autor:
Xiaolong Zheng, Jianai Sun, Xiujin Ye, Li Li, Rongrong Chen, Jingjing Zhu, Yuping Zhang, Hong-Hu Zhu, Xueying Li, Mixue Xie, Jie Jin, Lixia Zhu, Wenjuan Yu, Wanzhuo Xie, Mingyu Zhu, Lulu Wang, De Zhou, Hongyan Tong, Xiudi Yang
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Fatal hemorrhagic pneumonia is one of the most severe manifestations of Stenotrophomonas maltophilia (SM) infections. Here, we aimed to investigate the clinical characteristics of SM bacteremia and to identify the risk factors of hemorrhag
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-6 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Antibiotic-resistance reduces the efficacy of conventional triple therapy for Helicobacter Pylori infections worldwide, which necessitates using various treatment protocols. We used two protocols, doxycycline-based quadruple regimen and co
Autor:
Daniel Golparian, Tatyana Golubovskaya, Iryna Boiko, Magnus Unemo, Aliaksandra Aniskevich, Iryna Stanislavova, Aliaksandr Adaskevich, Iryna Shimanskaya, Susanne Jacobsson
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Limited antimicrobial resistance (AMR) data for Neisseria gonorrhoeae are available in Eastern Europe. We investigated AMR in N. gonorrhoeae isolates in the Republic of Belarus from 2009 to 2019, antimicrobial treatment recommended nationa